Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FVUML
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,289
Award facts
- Contract value 100% obligated
- $16,288.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,288.59 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injection). This is a firm fixed price, non-set-aside contract with an ultimate completion date of April 29, 2025, issued on April 28, 2025. AmerisourceBergen will perform and deliver from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supplier that has demonstrated extensive capability in fulfilling military and federal healthcare pharmaceutical requirements through competitive procurement. The parent IDC with DLA enables the company to supply a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for Forteo, a bone-building medication used in osteoporosis treatment, exemplifies the company's role in providing specialized pharmaceutical commodities across multiple therapeutic domains to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FVUML?
SPE2DB25FVUML was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 28, 2025.
How much is contract SPE2DB25FVUML worth?
The government has obligated $16,289 on SPE2DB25FVUML.
Is contract SPE2DB25FVUML an order under another contract?
Yes. SPE2DB25FVUML is a delivery order under SPE2DB25D3504, an indefinite delivery contract.
Was contract SPE2DB25FVUML competed?
The extent of competition for SPE2DB25FVUML was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award